Objectif The commercialisation of first-class research and the development of the European Biotechnology Healthcare sector faces major difficulties, in particular unmet financial needs and poor cooperation between sector actors. The absence of appropriate early-stag e risk capital severely impairs the formation of innovative start-up companies: Europe's start-ups need new forms of early-stage co-financing. The lack of short-term exit strategies that are able to provide acceptable returns on investment from biotechnology projects also impacts upon mature companies ability to seek additional investment. Experience suggests that European biotech is not enough collaboratively minded when measured against key performance indicators. Efficient and dynamic regional and EU-wide networking between actors is imperative if this situation is to be improved.This project will address both issues and contribute to enhancing access to finance through the formation of a network of professionals (from research to finance) sharing knowledge and best practice in order to provide models, toolkits and recommendations. After a precise identification of the specific needs and challenges in this sector through the analysis of both good practice and business failures, mapping and rating the avail able sources of financing will lead to practical propositions, such as setting up a financial toolkit for supporting innovative biotechnology businesses across the EU, and recommendations to help bridge the gaps. Working as a network, this project will also bring together the partners and their stakeholders in order to build a dynamic and sustainable EU community involving researchers, investors and entrepreneurs, fostering mutual understanding.The evolution of a community that develops and implements practices that meet the major players' needs is the hallmark of successful bioregions: this initiative intends to prove that this model can be extended nationally and internationally at the EU level. Champ scientifique social scienceseconomics and businessbusiness and managemententrepreneurship Programme(s) FP6-INNOVATION - Research and innovation in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme (FP6) 2002-2006 Thème(s) INNOVATION-2004-1.2.1.4 - Networking innovation actors by sectors Appel à propositions FP6-2004-INNOV-6 Voir d’autres projets de cet appel Régime de financement CA - Coordination action Coordinateur ATLANPOLE Contribution de l’UE Aucune donnée Adresse Chateau de la Chantrerie NANTES France Voir sur la carte Liens Site web Opens in new window Coût total Aucune donnée Participants (7) Trier par ordre alphabétique Trier par contribution de l’UE Tout développer Tout réduire TECHNOLGIEPARK HEIDELBERG GMBH Allemagne Contribution de l’UE Aucune donnée Adresse MarkPlatz 10 HEIDELBERG Voir sur la carte Liens Site web Opens in new window Coût total Aucune donnée INSTITUTE OF BALTIC STUDIES Estonie Contribution de l’UE Aucune donnée Adresse Kompanii 2 TARTU Voir sur la carte Liens Site web Opens in new window Coût total Aucune donnée CARDIFF UNIVERSITY Royaume-Uni Contribution de l’UE Aucune donnée Adresse 30-36 Newport Road CARDIFF Voir sur la carte Liens Site web Opens in new window Coût total Aucune donnée SCIERNCE PARK RAF S.P.A. Italie Contribution de l’UE Aucune donnée Adresse Via Olgettina, 58 MILAN Voir sur la carte Liens Site web Opens in new window Coût total Aucune donnée EUROPEAN BUSINESS ANGELS NETWORK Belgique Contribution de l’UE Aucune donnée Adresse c/o EURADA Avenue des Arts 12 BRUSSELS Voir sur la carte Liens Site web Opens in new window Coût total Aucune donnée DELOITTE AND TOUCHE LLP Royaume-Uni Contribution de l’UE Aucune donnée Adresse Stonecutter Court - 1 Stonecutter Street LONDON Voir sur la carte Liens Site web Opens in new window Coût total Aucune donnée EUROPEAN INVESTMENT FUND Luxembourg Contribution de l’UE Aucune donnée Adresse 43, Avenue J.F. Kennedy LUXEMBOURG Voir sur la carte Coût total Aucune donnée